Better metabolic control with insulin compared to sulfonylureas. This may allow us to identify etiological factors potentially obscured in analysis of heterogeneous patient groups with different pathogenesis and help us identify modifiable factors which may eventually lead to improved primary prevention. Sarafidis, Ch. Zhou, Z. Diabetologia 58, —
Latent autoimmune diabetes in adults - Wikipedia
However, those who achieve tight metabolic control do not present with a rapid decline in beta-cell function. That will help keep you well in the short term and help avoid complications of diabetes in the future. Patients with one or no features are unlikely to have LADA 99 percent negative predictive value. However, the autoimmune process seems to be milder and the progression of beta-cell failure slower; this is evidenced by the fact that LADA patients consistently display higher levels of C-peptide as indicator of insulin secretion Carlsson et al. Knowler, W. Lower specific antibody titers. We believe that clinicians and researchers should pay much more attention to this condition.